- Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings The Wall Street Journal
- Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar CNBC
- Lilly Ups Guidance on Weight Loss, Obesity Drugs’ Strength Bloomberg.com
- Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine statnews.com
- Eli Lilly Stock Rises on Earnings and Boost to Guidance Barron’s
Source link
